5-乙氧基邻苯二酚 | 28334-98-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 中文名称: 5-乙氧基邻苯二酚
• 英文名称: Phloroglucinmonoethylether
• 英文别名: 1,3-Benzenediol, 5-ethoxy-；5-ethoxybenzene-1,3-diol
• CAS: 28334-98-7
• 化学式: C₈H₁₀O₃
• 分子量: 154.166
• InChiKey: NCKTXJDJNMSYDR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  49.7
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2909499000

反应信息

• 作为反应物：
  描述：

  5-乙氧基邻苯二酚 以 盐酸 为溶剂， 生成 间苯三酚
  参考文献：
  名称：

  Process for preparing polyphenols

  摘要：

  通式为：##STR1## 其中R代表易于断裂的醚基，R'代表氢原子或较低的烷氧羰基，例如甲氧羰基或乙氧羰基，以及邻苯三酚的多酚类化合物，方法为将通式为：##STR2##其中R和R'的含义如上所述，与碱金属醇盐加热，并在需要时按已知方法将式I的产物转化为邻苯三酚，通过醚解和去除任何可能存在的酯基R'。

  公开号：

  US04112003A1
• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 盐酸 作用下， 生成 5-乙氧基邻苯二酚
  参考文献：
  名称：

  58.花椒的成分。第三部分 花椒素的组成

  摘要：

  DOI：

  10.1039/jr9370000286

文献信息

• BROMODOMAIN INHIBITORS FOR TREATING DISEASE
  申请人：Board of Regents, The University of Texas System

  公开号：US20160060260A1

  公开（公告）日：2016-03-03

  Disclosed herein are compounds and compositions useful in the treatment of bromodomain-containing protein-mediated diseases, such as cancer, having the structure of Formula I: Methods of inhibiting activity of a bromodomain-containing protein in a human or animal subject are also provided.

  本文披露了一种在治疗溴结构域含蛋白介导的疾病（如癌症）中有用的化合物和组合物，其具有Formula I的结构： 还提供了一种抑制人类或动物主体中溴结构域含蛋白活性的方法。
• MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME
  申请人：TABATA Masayoshi

  公开号：US20110224343A1

  公开（公告）日：2011-09-15

  The present invention provides a modifier for aromatic polyesters which enhances the melt fluidity of aromatic polyesters without a significant decrease in the heat resistance of the aromatic polyesters, and an aromatic polyester resin composition including the modifier for aromatic polyesters. The present invention relates to a modifier for aromatic polyesters comprising polyhydric phenol residues and residues of aromatic polycarboxylic acid, acid halide or acid anhydride thereof, and the modifier comprises a material having a structure composed of a first residue selected from the group consisting of divalent residues represented by Formula (I): —Ar—W 1 x —Ar— and by Formula (II): —Ar—, the first residues being bonded to two identical or different second residues selected from the group consisting of monovalent residues represented by Formula (III): and monovalent residues represented by Formula (IV): —O—C(O)—R 7 —.

  本发明提供了一种用于芳香族聚酯的改性剂，可以增强芳香族聚酯的熔融流动性，而不明显降低芳香族聚酯的耐热性，以及包括该改性剂的芳香族聚酯树脂组合物。本发明涉及一种用于芳香族聚酯的改性剂，包括多羟基酚残基和芳香族多羧酸、酸卤或其酸酐残基，该改性剂包括具有以下结构的材料：第一残基，选择自由式(I)所代表的二价残基：—Ar—W1x—Ar—和自由式(II)所代表的：—Ar—，第一残基与选择自由式(III)所代表的单价残基：和自由式(IV)所代表的单价残基：—O—C(O)—R7—的两个相同或不同的第二残基结合。
• Structural requirements of Dictyostelium differentiation-inducing factors for their stalk-cell-inducing activity in Dictyostelium cells and anti-proliferative activity in K562 human leukemic cells
  作者：Naomi Gokan、Haruhisa Kikuchi、Koji Nakamura、Yoshiteru Oshima、Kohei Hosaka、Yuzuru Kubohara

  DOI：10.1016/j.bcp.2005.06.002

  日期：2005.9

  signal molecule (chlorinated alkylphenone) that induces stalk-cell differentiation in the cellular slime mould Dictyostelium discoideum. It has also been shown that DIF-1 and its derivative (DIF-3) suppress cell growth in mammalian tumor cells. In the present study, in order to assess the chemical structure-effect relationship of DIF derivatives and to develop useful agents for the study of both Dictyostelium

  分化诱导因子-1（DIF-1）是一种亲脂性信号分子（氯化烷基苯甲酮），可在细胞粘液霉菌盘基网柄菌中诱导茎细胞分化。还已经显示出DIF-1及其衍生物（DIF-3）抑制了哺乳动物肿瘤细胞中的细胞生长。在本研究中，为了评估DIF衍生物的化学结构与效应的关系，并开发出对Dictyostelium的发展和癌症生物学研究有用的药物，我们合成了28种DIF-1和DIF-3的类似物并研究了它们的茎盘基网柄菌HM44细胞（突变株）中的-细胞诱导活性和人白血病K562细胞中的抗增殖活性。HM44细胞在内源性DIF-1产生中存在缺陷，应该适合用于DIF类似物诱导茎细胞活性的测定。在纳摩尔水平上，DIF-1及其某些衍生物是HM44细胞中良好的茎细胞诱导剂，而在微摩尔水平上，DIF-3和某些DIF-3衍生物在K562细胞中是有效的抗增殖剂。我们还试图寻找针对DIF-1和DIF-3的拮抗分子，但未能从此处使用的类似物
• Novel Cylopenta[B]Benzofuran Derivatives and the Utilization Thereof
  申请人：Diedrichs Nicole

  公开号：US20090018113A1

  公开（公告）日：2009-01-15

  The present application relates to a novel cyclopenta[b]benzofuran derivatives, processes for their preparation and their use for the manufacture of medicaments, in particular for the prophylaxis and/or therapy of acute or chronic disorders characterized by elevated cellular stress, by local or systemic inflammatory processes or by hyperproliferation.

  本申请涉及一种新型环戊[b]苯并呋喃衍生物，其制备过程及其用于制备药物，特别是用于预防和/或治疗因细胞应激升高、局部或全身性炎症过程或过度增殖而表现出的急性或慢性疾病的方法。
• COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS
  申请人：ARDELYX, INC.

  公开号：US20150336892A1

  公开（公告）日：2015-11-26

  The present disclosure is directed to compounds and methods for the treatment of disorders associated with fluid retention or salt overload, such as heart failure (in particular, congestive heart failure), chronic kidney disease, end-stage renal disease, liver disease, and peroxisome proliferator-activated receptor (PPAR) gamma agonist-induced fluid retention. The present disclosure is also directed to compounds and methods for the treatment of hypertension. The present disclosure is also directed to compounds and methods for the treatment of gastrointestinal tract disorders, including the treatment or reduction of pain associated with gastrointestinal tract disorders.

  本公开涉及化合物和方法，用于治疗与液体潴留或盐过量相关的疾病，例如心力衰竭（特别是充血性心力衰竭）、慢性肾脏疾病、晚期肾脏疾病、肝病和过氧化物酶体增殖物激活受体（PPAR）γ激动剂引起的液体潴留。本公开还涉及化合物和方法，用于治疗高血压。本公开还涉及化合物和方法，用于治疗胃肠道疾病，包括治疗或减轻与胃肠道疾病相关的疼痛。